MENAT News
Aspen announces exclusive licensing agreement with Wooshin Labottach for Lidocaine 700mg medicated plasters
Dublin, Ireland – Aspen Pharma Ireland Limited (“Aspen”), a subsidiary of Aspen Pharmacare Holdings Limited, a JSE-listed global multinational specialty pharmaceutical company, is pleased to announce that it has successfully concluded an exclusive licensing agreement with the Republic of Korea-based Wooshin Labottach Co. LTD, for Lidocaine 700mg medicated plasters, in selected European Union (EU) markets.
Read MoreAspen concludes exclusive European licensing agreement with Devintec Pharma for a patented women’s health medical device
Dublin, Ireland – Aspen Pharma Ireland Limited (“Aspen”), a subsidiary of Aspen Pharmacare Holdings Limited, a JSE-listed global multinational specialty pharmaceutical company, has concluded an exclusive licensing agreement (“Agreement”) with Swiss-based Devintec Pharma (“Devintec”) for Europe.
Read MoreAspen EME Kick-Off Meeting 2024
In January, the Aspen EME team gathered to start the new year 2024 and the post-merger journey with purpose, passion and unity. During this event held in Istanbul, we had the opportunity to get to know each other better, share experiences from our different markets, learn, and celebrate accomplishments. We also had the pleasure of…
Read MorePharmaBoardroom interview with Daniel Vella Friggieri on the merger of Aspen Europe & MENAT regions
In this interview with PharmaBoardroom, Daniel Vella Friggieri, Regional CEO EME, outlines the rationale behind the merger of Europe & MENAT regions
Read MoreNew Aspen International Commercial Region – Europe & Middle East
Over the last few months, the Aspen Group Executives completed an in-depth review of the international commercial portfolio to ensure focus and alignment with Aspen’s business strategy geared towards delivering its stated objectives. This led to a strategic decision to merge the current Europe and MENAT regions into one growth region to achieve the objectives…
Read MoreAspen, Saudi Chemical Company Holding and its subsidiary AJA Pharma enter into a memorandum of understanding
Dubai, United Arab Emirates – Aspen Healthcare FZ LLC (“Aspen Healthcare”), a subsidiary of Aspen Pharmacare Holdings Limited (“Aspen”), a global specialty and branded multinational pharmaceutical company, has entered into a memorandum of understanding (“MOU”) with Saudi Chemical Company Holding (“SCCH”), a well-known company in the local market of the Kingdom of Saudi Arabia, and…
Read MoreAspen donates life-saving emergency relief to patients in Turkey and Syria
Aspen, a leading global specialty and branded multinational pharmaceutical company, has positively responded to humanitarian calls for relief following the devastating 7.8 magnitude earthquake, along with a series of strong tremors and aftershocks, that tore through southeast Turkey and northwest Syria on 6 February 2023.
Read MoreSmile and skip the ouch!
We are very pleased to announce the launch of a website and social media pages that provide general information about Emla cream to the UAE audience.
Read MoreAHC Kick-Off Meeting 2022
The Aspen MENAT team gathered in October 2022 for a Kick-Off Meeting that took place at the beautiful Museum of The Future in Dubai, and Jumeirah Emirates Towers Hotel. This two-day event in the UAE was a special opportunity to share experiences from our different markets, learn from one another, celebrate accomplishments, and have fun!…
Read MoreAspen and BIT Pharma enter into an exclusive agreement for a Nicardipine-based Intracerebral Implant
Dubai, United Arab Emirates – Aspen Healthcare FZ LLC (“Aspen Healthcare”), a subsidiary of Aspen Pharmacare Holdings Limited (“Aspen”), a global specialty and branded multinational pharmaceutical company, has entered into an exclusive licensing agreement with Austrian-based biotech company Brain Implant Therapeutics (BIT) Pharma (“BIT Pharma”), for a Nicardipine-based intracerebral implant aimed at preventing vasospasm, a…
Read More